• Successful Year for Uniqsis

News & Views

Successful Year for Uniqsis

May 22 2008

Cambridge-based Uniqsis reported significant first year developments culminating with the first of its FlowSynâ„¢ Continuous Flow Reactor systems installed in pharmaceutical development laboratories.
Managing Director Martyn Fordham said “It’s been an incredibly busy but rewarding year. The development team took FlowSyn from concept design and first prototype phases through to beta trial systems for pilot customers and now to the manufacture of fully standards-tested production models, and all in less than 12 months.” Dr Mark Ladlow, a leading authority on flow chemistry has also joined the company as Chief Scientific Officer.
Mark was until recently head of the GSK Cambridge Technology Laboratory based within the University of Cambridge. New distributors for FlowSyn have been appointed in France, USA, Italy and India.

Digital Edition

International Labmate Buyers' Guide 2024/25

June 2024

Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...

View all digital editions

Events

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia

Miconex

Jul 31 2024 Chengdu, China

View all events